肝动脉化疗栓塞术后行经皮射频消融术治疗高危部位原发性肝癌的效果和安全性分析

孙巍; 丁晓燕; 陈京龙

doi:10.3969/j.issn.1001-5256.2016.12.021

肝动脉化疗栓塞术后行经皮射频消融术治疗高危部位原发性肝癌的效果和安全性分析

DOI: 10.3969/j.issn.1001-5256.2016.12.021

首都医科大学附属北京地坛医院肿瘤科首都医科大学附属北京地坛医院临床数据与样本资源库

基金项目:

基金项目:首都临床特色应用研究与成果推广(Z161100000516141)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1969
- HTML全文浏览量: 49
- PDF下载量: 417
- 被引次数: 0
出版历程
- 出版日期: 2016-12-20

Clinical effect and safety of percutaneous radiofrequency ablation following transcatheter arterial chemoembolization in treatment of primary liver cancer in high-risk locations

Research funding:

摘要

摘要: 目的探讨在肝动脉化疗栓塞术（TACE）基础上行经皮射频消融术（RFA）治疗高危部位肝癌病灶的临床疗效及安全性。方法收集2011年1月-2015年12月首都医科大学附属北京地坛医院收治的高危部位原发性肝癌患者64例。所有患者首先行TACE治疗,术后35 d行RFA治疗。RFA治疗均在CT引导下完成。主要观察治疗效果及不良反应发生情况。结果 64例患者中共包含76个病灶,均完成TACE及RFA治疗。术后1个月肿瘤完全消融率为81.5%（62/76）。术后随访664个月,至随访结束,肿瘤局部进展率为28.9%（22/76）;1、2、3年生存率分别为90.6%、78.1%、64.1%。随访期间手术严重并发症发生率为3.1%（1例出现肝脓肿、1例出现胆道出血）,分别在内科治疗和介入治疗后缓解且无后遗症。结论在TACE基础上行CT引导下经皮RFA治疗高危部位原发性肝癌是一种安全可行的治疗方案。
- 肝肿瘤 /
- 化学栓塞,治疗性 /
- 导管消融术 /
- 手术后并发症 /
- 治疗结果
Abstract: Objective To investigate the clinical effect and safety of percutaneous radiofrequency ablation( RFA) following transcatheter arterial chemoembolization( TACE) in the treatment of primary liver cancer in high- risk locations. Methods The patients with primary liver cancer in high- risk locations who were diagnosed and treated from January 2011 to December 2015 were enrolled. All the patients underwent TACE followed by CT- guided RFA 3- 5 days later. The treatment outcome and adverse events were observed. Results A total of64 patients with 76 lesions were enrolled and all of them completed TACE and RFA. At one month after surgery,the complete tumor ablation rate was 81. 5%( 62/76). The patients were followed up for 6 to 64 months after surgery; at the end of follow- up,the local tumor progression rate was 28. 9%( 22/76),and the 1-,2-,and 3- year survival rates were 90. 6%,78. 1%,and 64. 1%,respectively. The incidence rate of severe surgical complications during follow- up was 3. 1%( one patient each experienced liver abscess and hematobilia),and the patients achieved remission after medical treatment and interventional treatment without any sequel. Conclusion CT- guided RFA after TACE is a safe and feasible regimen for primary liver cancer in high- risk locations.
- liver neoplasms /
- chemoembolization,therapeutic /
- catheter ablation /
- postoperative complications /
- treatment outcome

HTML全文

参考文献(18)

[1]WANG Y,LUO Q,LI Y,et al.Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas:a meta-analysis of randomized and non randomized controlled trials[J].PLo S One,2014,9(1):e84484.

[2]TERATANI T,YOSHIDA H,SHIINA S,et al.Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations[J].Hepatology,2006,43(5):1101-1108.

[3]LIU LL.The development of radiofrequency ablation of hepatic carcinoma in high-risk locations[J].Chin Clin Oncol,2012,17(5):475-478.(in Chinese)刘丽莉.高危部位肝癌射频消融治疗的进展[J].临床肿瘤学杂志,2012,17(5):475-478.

[4]Ministry of Health of the People’s Republic of China.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.

[5]BRUIX J,SHERMAN M,LLOVET JM,et al.Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference.European Association for the Study of the Liver[J].J Hepatol,2001,35(3):421-430.

[6]GOLDBERG SN,CHARBONEAU JW,DODD GD,et al.Imageguided tumor ablation:proposal for standardization of terms and reporting criteria[J].Radiology,2003,228(2):335-345.

[7]de LIMA LOPES GJR,DICKSEY JS,PETERS WP,et al.Final results of a prematurely discontinued phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma[J].Cancer Chemother Pharmacol,2011,68(4):1067-1073.

[8]GAZELLE GS,GOLDBERG SN,SOLBIATI L,et al.Tumor ablation with radio-frequency energy[J].Radiology,2000,217(3):633-646.

[9]WONG SN,LIN CJ,LIN CC,et al.Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations[J].AJR Am J Roentgenol,2008,190(3):w187-195.

[10]CHA DI,LEE MW,RHIM H,et al.Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations[J].Korean J Radiol,2013,14(2):240-247.

[11]LIN JW,LIN CC,CHEN WT,et al.Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma(3.1-4cm)and in high-risk locations[J].Kaohsiung J Med Sci,2014,30(8):396-401.

[12]KELOGRIGORIS M,LASPAS F,KYRKOU K,et al.Percutaneous radiofrequency ablation for malignant liver tumours in challenging locations[J].J Med Imaging Radiat Oncol,2012,56(1):48-54.

[13]YAMANAKA T,YAMAKADO K,TAKAKI H,et al.Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas[J].Jpn J Radiol,2012,30(7):553-559.

[14]ZHANG L,YIN X,GAN YH,et al.Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria[J].BMC Gastroenterol,2014,14(1):11.

[15]YI Y,ZHANG Y,WEI Q,et al.Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone[J].Chin J Cancer Res,2014,26(1):112-118.

[16]DU JK,ZHANG MD,ZOU Y,et al.Large dose heat lipiodol TACE combined with radiofrequency ablation in treatment of hepatic metastases of digestive tract cancer[J].Clin J Med Offic,2014,42(9):898-900.(in Chinese)独建库,张明德,邹洋,等.大剂量热碘的TACE联合射频消融术治疗消化道癌肝转移[J].临床军医杂志,2014,42(9):898-900.

[17]BILCHIK AJ,WOOD TF,ALLEGRA D,et al.Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms:a proposed algorithm[J].Arch Surg,2000,135(6):657-662.

[18]LI M,LI ZY,TIAN JK,et al.Clinical study of ultrasound-guided percutaneous radiofrequency ablation for primary hepatic carcinoma adjacent to the diaphragm[J].J Clin Hepatol,2015,31(4):573-577.(in Chinese)李猛,李志艳,田江克,等.超声引导经皮射频消融对邻近横膈部原发性肝癌治疗的有效性与安全性评价[J].临床肝胆病杂志,2015,31(4):573-577.

施引文献

资源附件(0)

访问统计